Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.

The international journal of biochemistry & cell biology·2018
Same author

Low-Temperature Carbide-Mediated Growth of Bicontinuous Nitrogen-Doped Mesoporous Graphene as an Efficient Oxygen Reduction Electrocatalyst.

Advanced materials (Deerfield Beach, Fla.)·2018
Same author

Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer.

Cancer biology & therapy·2018
Same author

A systematic analysis of the association between Notch1 expression and the patients with digestive tract cancers.

Biomarkers in medicine·2018
Same author

Occurrence and regression of BK polyomavirus associated carcinoma: a clinical and next-generation sequencing study.

Clinical science (London, England : 1979)·2018
Same author

Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.

Molecular oncology·2018

Related Experiment Video

Updated: Jun 25, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

6.8K

Labeling and Diagnostic Value of miRNA-28-3p in Patients with Nasopharyngeal Carcinoma.

Gang Huang, Na Zhao, Jianwei Wu

    Alternative Therapies in Health and Medicine
    |May 30, 2024
    PubMed
    Summary
    This summary is machine-generated.

    MicroRNA-28-3p is overexpressed in nasopharyngeal carcinoma (NPC), inhibiting tumor growth and metastasis by targeting BIN1. Its expression levels are a sensitive indicator for NPC prediction.

    More Related Videos

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
    08:12

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

    Published on: March 14, 2019

    5.5K
    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
    08:14

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

    Published on: October 26, 2017

    15.6K

    Related Experiment Videos

    Last Updated: Jun 25, 2025

    Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
    06:01

    Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

    Published on: June 7, 2016

    6.8K
    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
    08:12

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

    Published on: March 14, 2019

    5.5K
    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
    08:14

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

    Published on: October 26, 2017

    15.6K

    Area of Science:

    • Oncology
    • Molecular Biology
    • Biomarker Discovery

    Background:

    • Nasopharyngeal carcinoma (NPC) is a significant health concern.
    • Understanding the molecular mechanisms underlying NPC progression is crucial for developing effective diagnostic and therapeutic strategies.

    Purpose of the Study:

    • To investigate the role of microRNA-28-3p (miRNA-28-3p) in nasopharyngeal carcinoma (NPC).
    • To determine if miRNA-28-3p targets BIN1 and influences NPC cell behavior.
    • To evaluate miRNA-28-3p as a potential predictive biomarker for NPC.

    Main Methods:

    • Analysis of miRNA-28-3p and BIN1 expression in NPC tissues and cell lines.
    • Utilizing techniques such as PCR, Western blotting, CCK-8, and flow cytometry.
    • Investigating the functional impact of miRNA-28-3p inhibition on NPC cell proliferation, apoptosis, invasion, and migration.

    Main Results:

    • miRNA-28-3p was significantly upregulated in NPC tissues and cells compared to normal controls.
    • miRNA-28-3p expression demonstrated a predictive performance for NPC with an AUC > 0.75.
    • Inhibition of miRNA-28-3p led to increased apoptosis and BIN1 protein levels, while decreasing proliferation, invasion, and migration.

    Conclusions:

    • miRNA-28-3p is overexpressed in NPC and acts as a tumor suppressor by targeting BIN1, inhibiting proliferation, migration, and invasion, while promoting apoptosis.
    • miRNA-28-3p expression levels are a sensitive biomarker for NPC prediction.
    • These findings highlight miRNA-28-3p's potential as a diagnostic biomarker and therapeutic target for NPC.